“Efficacy and Safety of Tralokinumab in US Adults with Moderate-to-Severe Atopic Dermatitis: A Post-hoc Analysis of ECZTRA3”, J of Skin, vol. 7, no. 2, pp. 686–695, Mar. 2023, doi: 10.25251/skin.7.2.5.